Key Market Indicators
The prevalence of HIV/AIDS in Algeria is set to reach 1,050 people aged 0-14 by 2026, a 3.1% year-on-year increase on the 862 people aged 0-14 in 2021. Since 1995, demand has grown by 11.5% each year. In 2021, Algeria ranked 61st in the world, behind Morocco with 862 people aged 0-14. Nigeria, Mozambique and Tanzania took 2nd, 3rd and 4th place respectively. The treatment coverage of people living with HIV in Algeria hit 90% in 2021, a 5.9 point rise from the 85% in 2020. Since 2005, the market has grown by 3.2 points each year. In 2021, Algeria was 12th in the world, behind Australia with 90% coverage. Cape Verde, Latvia and Zimbabwe came in 2nd, 3rd and 4th place respectively.